---
trial_id: 330
discovery_date: 2022-04-02 17:30:16.062329
date: 2022-04-02 17:30:16.062329
title: "Pituitary adenylate cyclase activating polypeptide in stressed patients with Multiple sclerosis (MS) or clinically isolated syndrome suggestive for MS under treatment with glatiramer acetate (PACAM..."
summary: |
  <p>EudraCT Number: 2009-011088-35<br />Sponsor Protocol Number: PACAMUS<br />Sponsor Name: Philipps-Universität Marburg<br />Start Date: 2010-03-24<br />Medical condition: Patients with Multiple Sclerosis (MS) or Clinically isolated syndrome suggestive for MS (CIS) are investigated. The main objective is to conserve data about changes in the VIP/PACAP (vasoactive int...<br />Disease: <br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011088-35/DE">DE</a> (Completed)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2009-011088-35'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2009-011088-35<br />Sponsor Protocol Number: PACAMUS<br />Sponsor Name: Philipps-Universität Marburg<br />Start Date: 2010-03-24<br />Medical condition: Patients with Multiple Sclerosis (MS) or Clinically isolated syndrome suggestive for MS (CIS) are investigated. The main objective is to conserve data about changes in the VIP/PACAP (vasoactive int...<br />Disease: <br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011088-35/DE">DE</a> (Completed)</p>